Table 1.
Anthropometric and lifestyle data, comorbidities, and laboratory test results of patients with psoriasis (n=11) and control subjects (n = 33)
| Variables | Control group (n = 33) | Psoriatic group (n = 11) | p-value |
|---|---|---|---|
| Age (years) | 60 ± 9 | 64 ± 12.5 | 0.391* |
| Ethnicity | 0.479† | ||
| White | 21 (63.6%) | 5 (45.5%) | |
| Pardo (multiracial)/Black | 12 (36.4%) | 6 (54.5%) | |
| BSA (m2) | 1.92 ± 0.20 | 1.94 ± 0.23 | 0.835‡ |
| Weight (kg) | 79.8 ± 15.1 | 84.7 ± 21.6 | 0.494‡ |
| BMI (kg/m2) | 27.2 ± 4.7 | 30.9 ± 5.9 | 0.079‡ |
| Waist-hip ratio | 0.96 ± 0.06 | 0.97 ± 0.05 | 0.576‡ |
| Habits | |||
| Smoking | 7 (21.2%) | 6 (54.5%) | 0.086† |
| Alcohol consumption | 10 (30.3%) | 3 (27.3%) | 1.000§ |
| Comorbidities | |||
| Hypertension | 11 (33.3%) | 7 (63.6%) | 0.093§ |
| Dyslipidemia | 10 (30.3%) | 3 (27.3%) | 1.000§ |
| Diabetes mellitus | 6 (18.2%) | 3 (27.3%) | 0.669§ |
| Laboratory tests | |||
| Total Cholesterol (mg/dL) | 198 ± 39.8 | 252 ± 43.5 | < 0.001* |
| HDL Cholesterol (mg/dL) | 46 ± 13.5 | 38 ± 16.5 | 0.283* |
| LDL Cholesterol (mg/dL) | 118 ± 40.8 | 167 ± 24 | < 0.001* |
| C-reactive protein (mg/L) | 1 ± 1.2 | 7.6 ± 35.4 | < 0.001* |
*
Wilcoxon Mann-Whitney test for independent samples (mean ± SD),
†
chi-square test of independence;
‡
Student's t-test for independent samples (mean ± SD),
§
Fisher's exact test; BMI: body mass index; BSA: body surface area.